Is Citius Pharmaceuticals, Inc. FDA approved?

Citius Pharmaceuticals, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Citius Pharmaceuticals, Inc. make?

1 product is listed under Citius Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Citius Pharmaceuticals, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 1
Live patents: 3
Countries: 0

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
8440170	SUPRENZAphentermine hydrochloride	product	Mar 2029

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
LYMPHIR	denileukin diftitox-cxdl	injection, powder, lyophilized, for solution, intravenous	52658-7777BLA

Enquiry

Common questions

Is Citius Pharmaceuticals, Inc. FDA approved?: Citius Pharmaceuticals, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Citius Pharmaceuticals, Inc. make?: 1 product is listed under Citius Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.